This is the Resverlogix patent for co-treatment with RVX-208 and rosuvastatin that Resverlogix was referring to in their
September 2013 news release.
COMPOSITIONS AND THERAPEUTIC METHODS FOR ACCELERATED PLAQUE REGRESSION
http://www.freepatentsonline.com/y2016/0206617.htmlGo to that website above and scroll down a bit and you can get the pdf (or try clicking
here).
Pretty cool actually. I don't think I ever saw them break down the MACE numbers by type of statin and HDL level. If nothing else, just scroll through and look at the images.
Abstract:
The invention comprises methods for treating and/or preventing cardiovascular, cholesterol, and lipid related disorders, including atherosclerosis, through co-administration of therapeutically effective amounts of RVX-208 or a pharmaceutically acceptable salt thereof and rosuvastatin or a pharmaceutically acceptable salt thereof. The invention further provides compositions comprising a therapeutically effective amount of RVX-208 or a pharmaceutically acceptable salt thereof and a therapeutically effective amount of rosuvastatin or a pharmaceutically acceptable salt thereof.